dysfunction as an expected postoperative complication after liver surgery can be further worsened in metastatic patients whose liver function is already impaired by several chemotherapy regimens.
Furthermore, morphine may also impact on the oncologic risk of recurrence, and despite controversial results, morphine has been reported to alter antitumor immune potential, 7 and stress response. 8 Indeed, current trends towards reduction of the consumption of morphine have emerged and have been adopted in enhanced recovery programs after surgery. 9 Alternative techniques to reduce morphine consumption are, therefore, attractive and mainly involve epidural analgesia (EA) or continuous wound infiltration (CWI) methods. EA allows to achieve a reduced consumption of conventional analgesics and specially morphine in patients undergoing hepatic resection. 10 However, the use of EA in liver surgery still remains a controversial subject, though. Perceived disadvantages of EA include intravenous fluid overload, coagulopathy after liver resection, epidural haematoma, and increased blood transfusion requirements. 10 Some postoperative kidney dysfunctions have also been reported in major hepatectomy. 11 Analgesic CWI of local amide-type anesthetics such as ropivacaine are also attractive especially to relief acute postoperative pain. 12 Encouraging results were achieved using CWI in major abdominal surgery and more specifically in open liver surgery, and enhanced recovery outcomes have even been reported. However, results came from series with limited sample sizes. [13] [14] [15] [16] [17] We have therefore designed this prospective randomized doubleblind controlled trial to assess the impact of preperitoneal CWI administration with ropivacaine vs placebo during 96 hours on the consumption of analgesics in patients with liver metastases undergoing opened hepatectomy. 
| MATERIALS AND METHODS
This
| Patient population

| Randomization and blinding
Patients were randomized in a 1:1 ratio into the ropivacaine (ROP) or the placebo (P) arm. The randomization was performed the day before the surgery with a computer-generated system using a permuted blocks method of two and four patients to avoid an unbalanced baseline profile between groups. After randomization, the pharmacist prepared a 40-mL syringe of 3.75 mg/mL ROP (1-propyl-2′,6′-pipecoloxylidide hydrochloride, Naropin; AstraZeneca, France, Courbevoie, France), or 0.9% saline solution for bolus infusion, as well as an elastomeric pump (Coopdech Ballonjector;
Daiken Medical, Japan) with 400 mL of 2 mg/mL ROP or 0.9% saline solution for CWI, adjusted to run at 8 mL/h. The infusion medication was masked to health care professionals and patients until the study was completed. To note, no stratification on the type of wound incision has been performed.
| Perioperative care
Each patient received instructions on the patient-controlled analgesia 
| Postoperative care
Patients transferred to the recovery ward were extubated and monitored until observations and pain scores were acceptable, then remained in the high-dependency unit until discharge. Pain intensity was measured on arrival to the postoperative intensive care unit and then every 6 hours with a 0-to-100 mm visual analog scale (VAS).
Acetaminophen and nefopam were given as rescue medication in case of persistent pain (VAS >60 mm). Oral fluids started around 10 AM the day after surgery, and the light meal was given in the first evening.
| Outcomes
The primary endpoint was defined as the total morphine Intraoperative and postoperative data are presented in Table 2 .
The anesthetic parameters showed no significant differences in the median values between groups. The median intraoperative dose of acetaminophen was 13. mm; P = 0.054). The VAS distribution showed that patients experienced less pain in the ROP group compared with those in the control group, though this was not statistically significant. Of note, no gender differences were reported in the pain experienced.
The incidences of postoperative side effects are reported in Table 3 .
No significant differences were observed between arms regarding the cardiac monitoring (blood pressure and heart rate), recovery of gastrointestinal solid function and median hospitalization length of stay.
The median delay for recovery of gas function for patients in the ROP arm tends to be reduced when compared with the patients in the P arm (P = 0.075).
AEs were observed at least once in 48 (57%) patients; most frequently reported AEs (all grades) were gastrointestinal dysfunctions in Two patients in major violation of eligibility criteria (one primitive liver and one gallbladder tumor without any liver metastases), *seven patients not treated. *Reasons for not treating the eight patients involved hepatectomy canceled (n = 5), intraoperative complication (n = 1), or inability of place the catheter (eventration, nonindividualized preperitoneal surgical plan) (n = 2). P, placebo; ROP, ropivacaine poorly described in open hepatectomy. However, local infusions of anesthetics have been reported to improve pain relief in open liver surgery in the oncology setting, after we had designed our trial.
| Comparison with other studies
14,15,17 A one-third global decrease in cumulative morphine consumption over 72 hours was reported in 48 patients with cancer (predominantly male) with hepatocellular carcinoma or colorectal liver metastases having received 0.25% ROP CWI. 14 A sufentanil reduction by almost half was achieved in 44 patients undergoing opened hepatectomy who were receiving 0.3% ROP CWI, and an improved postoperative recovery was observed. 15 CWI and traditional analgesia were methods reported as postoperatively comparable at most time points. 17 The present randomized study reinforces the idea that CWI could be an efficient method allowing to reduce analgesic consumption and should be considered as a suitable option for pain management in open liver surgery. Nevertheless, benefit in recovery should be further explored.
| Hypotheses
In a meta-analysis comparing transverse vs midline incision for | 51
| Strengths of the trial
We reported the analysis of a large cohort of patients for which an infiltration over a long period had been preferred and the dose reductions reported in mg/kg can be easily compared for replicate trials.
ROP, pharmacologically similar to bupivacaine, is nevertheless associated with less cardiac and central nervous system toxicities which allow larger administration doses. 27 In the current study, no cardiac toxicity was observed. A close monitoring of the cardiac function (daily electrocardiograms and heart rate) was performed for these patients undergoing a 4-day infiltration after hepatic resection.
Despite a large amount of ROP administrated during the postoperative period, the highest median blood concentration reached was 2.6 µg/mL, far below the known toxic threshold. 28 This reduced concentration may partially be attributed to its elimination driven by the suction drains installed in the abdominal cavity. Moreover, up to 94% of the ROP binds to the plasma α1-acid glycoprotein-known to increase in surgical stress-thus enabling the reabsorption of the bound ROP to occur and thereby to reduce the associated toxicity. 29 Postoperative nausea and vomiting were AE in accordance with those reported by Bianconi et al. 30 A longer ROP CWI was preferred in the current study with the aim of improving recovery and reducing the length of hospital stay. CWI is associated with a reduced time to recovery after opened liver resection. 12, 13, 31 Postoperative ileus is a major concern, 9 and enhanced recovery after surgery (ERAS) protocols should be recommended. 32 The choice of the postoperative analgesic is obviously crucial, 33 and a better postoperative recovery is achieved using sufentanil PCA. 15 The pain resulting from abdominal distension remains a challenge for physicians that cannot be relieved with a simple adaptation of the study drug concentrations or an adjustment of the duration of CWI exclusively, but assumes a precise choice of the opioid medication itself, and a better understanding of the visceral pain's physiopathology. 34 It highlights that CWI should be further explored as a relevant option to reduce the use of morphine and morphine-related side effects, concomitant to the implementation of the ERAS program. 
| Limitations of this trial
The results of this trial need to be considered in the context of its limitations:
1. We observed a clear trend leading towards reduction of analgesic consumption. However, the power analysis initially planned hundred patients for statistical validity and results from this ambitious series need to be confirmed in a randomized trial successfully completed.
2.
No stratification was performed according to the incision type.
3.
Our results failed to improve recovery and length of hospital stay; no enhanced recovery program had been adopted as standard care when the study was initiated. PERES-BACHELOT ET AL.
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4. Unbound ROP concentrations were not determined. No conclusion regarding safety can be made since our study was not designed as a pharmacological trial.
5.
The median VAS pain score was low in both groups and thus attested the appropriate control of postoperative pain with no gender differences, and severe pain needs to be further explored.
We were concerned about the high dose of acetaminophen observed in the control arm since it could potentially have skewed the results.
However, this was eliminated with regard to the high dose of morphine administrated to a higher proportion of patients in the control group.
| Implications of findings
In patients with cancer , the use of postoperative opioids in acute pain management is controversial, the issue is particularly acute when EA is contraindicated. In animal models, opioids are immunosuppressive through mediation of inflammation and modulation of angiogenesis; the associated stress to surgical procedures can also impair immunity.
Alternative multimodal pain management techniques were therefore required to reduce the negative impact of opioids and in attempting to minimize surgical stress. Regional anesthesia became a rational choice for pain management. In addition, to reduce the use of opioid analgesics is all the more important since it might also reduce the incidence of tumor relapse. 8 Indeed, considerable evidence suggest that anesthesia can have both direct and indirect effect on cancer cell survival and metastasis.
Despite the potentially interesting approach reported in small retrospective studies, regional anesthesia had no overall survival, recurrencefree survival, or biochemical recurrence-free survival benefit; only large randomized controlled trials would allow to determine the impact of regional anesthesia and analgesia on cancer recurrence and survival. 37 One advantage in using ROP CWI is to allow prolonged infusion through the entire duration of surgery and during the postoperative period without any specific surveillance in contrast to lidocaine administration that is usually used for short periods, or through longer perioperative intravenous administration with an appropriate monitoring and surveillance. 38 It should nevertheless be noted that CWI exclusively highlighted a lowering of morphine use in the first two days in this series.
| Conclusions and implications for practice
Preperitoneal CWI of 2 mg/mL ROP should be further explored as a useful adjunct in a multimodal approach to reduce morphine and more generally opioids consumption after opened hepatectomy surgery and this method deserves to be maintained as a complementary therapeutic option in multimodality approaches for postoperative pain management.
